The medical device industry is a knowledge-intensive, capital-intensive industry with a cross-section of high-tech fields such as bioengineering, electronic information and medical imaging. Venture capital is active in emerging cross-cutting areas. In 2017, the global medical device industry invested 2.9 billion US dollars. The United States is still an investment gathering place, which coincides with the market size distribution of the global medical device industry. The core technology is industry development. The foundation. The characteristics of 27 major medical device investment events in the world are that the enterprises with large investment amount are the vane of the development of the industry, and the high-value medical equipment enterprises with large scale are still hot investment.
The global medical device industry has invested 2.9 billion US dollars, and the United States is still an investment gathering place.The introduction of investment is the only way for enterprises to grow and integrate and develop the industry. The injection and integration of the capital market has made the medical device industry a qualitative leap to a certain extent. In 2017, the global investment in the medical device industry reached 2.9 billion US dollars; there were 27 major investment events in the global medical device industry, 3 in China and 24 in foreign countries.
Chart 1: Summary of major investment events in the global medical device industry in 2017 (in millions of US dollars)
From the regional analysis of global medical device financing, in 2017, the United States received 16 financings, accounting for 59.3%; three in China, accounting for 11.1%, respectively, Shanghai Fangrun Medical, Anhan Medical, and Guangdong Ruiguang Kangtai . It can be seen that the United States has become an investment gathering place in the medical device industry, which coincides with the distribution of the market scale of the global medical device industry. Most of the leading companies in the medical device industry are gathered in the United States, and the core technology is still the development of the industry. this.
Figure 2: Regional distribution of financing events in the global medical device industry in 2017 (unit: %)
Dimensional analysis of the amount of financing obtained from enterprises, capital inflows with a financing amount of more than 100 million US dollars is not uncommon, indicating that the global medical device industry has considerable market potential. There are 3 financings of more than 100 million US dollars, totaling 20.6 billion US dollars, accounting for 71.15% of total financing; 6 financings of 50 million US dollars to 100 million US dollars, totaling 352 million US dollars, accounting for 12.16% of the total; 30 million US dollars - 5000 Ten thousand dollars of financing, totaling 398 million US dollars, accounting for 13.75% of the total; there are 8 financings below 30 million US dollars, a total of 85 million US dollars, accounting for 2.95%.
The three largest VC events with the largest quota have the meaning of vane:
Early-stage cancer screening company Grail receives $900 million in Series B round-up financing, which is used to support ongoing research and development of CirculaTIng Cell-free Genome Atlas based on high-throughput sequencing and data science. And other large-scale clinical trials. It can be seen that in vitro diagnosis and early screening require a large investment in research and development, which also indicates that in vitro diagnosis is an important development direction of the medical device industry.
Verily Life Sciences, a subsidiary of Alphabet, develops small blood glucose detectors, smart contact lenses, retinal imaging solutions and surgical robots, and receives $800 million in financing from Temasek. This is the only financing in the global medical device industry in the global medical device industry in 2017, and the amount of financing is huge, and the future prospects of Internet medical care are worth looking forward to.
Guardant Health is committed to tracking and detecting cancer through DNA fragment testing in the bloodstream, and has received $360 million in Series E financing. Guardant Health is also a company focused on the field of in-vitro diagnostics. Two of the three more than $100 million incidents are in-vitro diagnostics. It can be seen that in the future, in vitro diagnosis and early screening will become the development focus of medical health.
Chart 3: Global medical device industry financing amount distribution in 2017 (unit: million US dollars, %)
Further analysis from the global medical device financing stage, there were 7 incidents of obtaining B round financing in 2017, 5 strategic investments, 4 C round financing, and 3 D round financing. It can be seen that investment institutions invest more in the medical device industry with core technology products or enterprises with a preliminary market size.
Chart 4: Number of different round financing events in the global medical device industry in 2017 (unit: from)
In terms of the fields involved in the global medical device industry investment, in 2017, the main investment is active in the field of high-value medical devices with infiltration and application of emerging technologies such as drug delivery systems, in vitro diagnostics, orthopedics, nerves, and heart. With the advancement of technology, the world continues to develop high-tech, so that the sensitivity, applicability, early diagnosis, micro-analysis, specificity and efficiency of medical treatment are greatly improved, so as to meet the needs of the medical device market. In the future, high-value medical devices will be the focus of investment in the industry.
Figure 5: Distribution of medical fields in the global medical device industry in 2017 (unit: %)
Structure Ceramics,Alumina Ceramic Bracket,Industrial Machinery Ceramics,Al2O3 Ceramic Tube
Yixing Guangming Special Ceramics Co.,Ltd , https://www.yxgmtc.com